LR Health & Beauty Presents New Fitness Brand
1.2.2022 13:53:00 CET | Business Wire | Press Release
With the start of 2022, LR Health & Beauty, headquartered in Ahlen/Westphalia (Germany), is launching its new fitness brand LR:GO, which comprises products as well as a holistic coaching package with workout videos, diet plans and expert tips. With the new range, the company is aiming to get people to become more active and fit. LR is also drawing on the expertise of Dr. med. Matthias Manke, who – as a specialist in orthopaedics and trauma surgery – has already looked after track and field athletes at the Bochum-Wattenscheid Olympic training centre as well as footballers of the Bundesliga, the German premier league.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220201005696/en/
Dr. med. Matthias Manke (left) and Andreas Friesch, CEO at LR, are looking forward to promoting exercise and a healthy lifestyle. (Photo: Business Wire)
New brand underlines faith in active lifestyle
LR:GO caters to the body’s needs before, during and after exercising. “For us, the new brand underlines the faith in an active lifestyle. This includes a healthy diet and regular training sessions, which are underpinned by the products,” explains Andreas Friesch, CEO and spokesperson for the management of LR.
The product system is based on a sophisticated nutrient concept. “In addition, when developing the products, we made sure they are free from ingredients of animal origin and are therefore also suitable for vegans,” says Katharina Schorez, Head of Marketing at LR. It is also worth mentioning that there is one bespoke product for each of the three training phases – i.e. the phase before, during and after exercising.
Dr. med. Matthias Manke as scientific advisor for LR:GO
As part of the launch of the new fitness brand, LR has managed to gain Dr. med. Matthias Manke as a strong partner. The Bochum-based orthopaedic specialist and trauma surgeon is one of Germany’s most eminent medics. He looks after top athletes (e.g. at the Olympic training centre in Bochum-Wattenscheid and in the Bundesliga, Germany’s premier league) and has made a name for himself as an expert in the field of sports medicine through regular TV contributions and magazine columns. As part of the collaboration with LR, Dr. Manke will offer valuable tips on the subject of sport at events and on communication media.
LR Group
Following the motto "More quality for your life", the LR Group with headquarters in Ahlen/Westphalia (Germany) produces and markets various health and beauty products in 28 countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220201005696/en/
Contact information
LR Health & Beauty
Almut Kellermeyer
+49 2382 7658 106
A.Kellermeyer@LRworld.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press Release
The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products. “As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult smokers transition away from combustible cigarettes,” said Stacey Kenned
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom